Association of plasma biomarkers of fruit and vegetable intake with incident type 2 diabetes: EPIC-InterAct case-cohort study in eight European countries.


Journal

BMJ (Clinical research ed.)
ISSN: 1756-1833
Titre abrégé: BMJ
Pays: England
ID NLM: 8900488

Informations de publication

Date de publication:
08 07 2020
Historique:
entrez: 10 7 2020
pubmed: 10 7 2020
medline: 23 7 2020
Statut: epublish

Résumé

To investigate the association of plasma vitamin C and carotenoids, as indicators of fruit and vegetable intake, with the risk of type 2 diabetes. Prospective case-cohort study. Populations from eight European countries. 9754 participants with incident type 2 diabetes, and a subcohort of 13 662 individuals from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort of 340 234 participants: EPIC-InterAct case-cohort study. Incident type 2 diabetes. In a multivariable adjusted model, higher plasma vitamin C was associated with a lower risk of developing type 2 diabetes (hazard ratio per standard deviation 0.82, 95% confidence interval 0.76 to 0.89). A similar inverse association was shown for total carotenoids (hazard ratio per standard deviation 0.75, 0.68 to 0.82). A composite biomarker score (split into five equal groups), comprising vitamin C and individual carotenoids, was inversely associated with type 2 diabetes with hazard ratios 0.77, 0.66, 0.59, and 0.50 for groups 2-5 compared with group 1 (the lowest group). Self-reported median fruit and vegetable intake was 274 g/day, 396 g/day, and 508 g/day for participants in categories defined by groups 1, 3, and 5 of the composite biomarker score, respectively. One standard deviation difference in the composite biomarker score, equivalent to a 66 (95% confidence interval 61 to 71) g/day difference in total fruit and vegetable intake, was associated with a hazard ratio of 0.75 (0.67 to 0.83). This would be equivalent to an absolute risk reduction of 0.95 per 1000 person years of follow up if achieved across an entire population with the characteristics of the eight European countries included in this analysis. These findings indicate an inverse association between plasma vitamin C, carotenoids, and their composite biomarker score, and incident type 2 diabetes in different European countries. These biomarkers are objective indicators of fruit and vegetable consumption, and suggest that diets rich in even modestly higher fruit and vegetable consumption could help to prevent development of type 2 diabetes.

Identifiants

pubmed: 32641421
doi: 10.1136/bmj.m2194
pmc: PMC7341350
doi:

Substances chimiques

Biomarkers 0
Carotenoids 36-88-4
Ascorbic Acid PQ6CK8PD0R

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

m2194

Subventions

Organisme : Medical Research Council
ID : MC_UU_00006/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L003120/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00006/3
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from European commission, UK Medical Research Council, British Heart Foundation, and National Institute for Health Research Cambridge Biomedical Research Centre for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy, or views of the International Agency for Research on Cancer/WHO.

Références

Br J Nutr. 2015 May 14;113(9):1396-409
pubmed: 25850683
Int J Epidemiol. 1997;26 Suppl 1:S1-5
pubmed: 9126528
Eur J Clin Nutr. 2017 Jan;71(1):83-91
pubmed: 27530474
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Sep 25;824(1-2):132-8
pubmed: 16046288
Diabetologia. 2009 Jan;52(1):97-105
pubmed: 18985315
JAMA. 1999 Sep 15;282(11):1073-5
pubmed: 10493207
Eur J Clin Nutr. 2005 Dec;59(12):1387-96
pubmed: 16160702
BMJ Open Diabetes Res Care. 2015 Dec 01;3(1):e000147
pubmed: 26688736
Diabetes Care. 2018 Apr;41(4):680-687
pubmed: 29282203
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
BMJ. 2018 Jun 13;361:k2234
pubmed: 29898883
J Clin Epidemiol. 2007 Apr;60(4):350-5
pubmed: 17346608
Cell Host Microbe. 2018 Jun 13;23(6):705-715
pubmed: 29902436
Br J Nutr. 2015 Nov 14;114(9):1331-40
pubmed: 26349405
Am J Clin Nutr. 2009 Aug;90(2):429-37
pubmed: 19491386
Eur J Clin Nutr. 2004 Aug;58(8):1166-73
pubmed: 15054430
Am J Clin Nutr. 2018 Jul 1;108(1):136-155
pubmed: 29931038
Curr Opin Lipidol. 2015 Dec;26(6):594-5
pubmed: 26780012
Curr Opin Clin Nutr Metab Care. 2016 Nov;19(6):471-476
pubmed: 27490306
Eur J Clin Nutr. 2012 Oct;66(10):1082-92
pubmed: 22854878
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
BMJ Open. 2014 Nov 05;4(11):e005497
pubmed: 25377009
Diabetologia. 2008 Jan;51(1):47-53
pubmed: 17994292
Eur J Clin Nutr. 2007 Sep;61(9):1037-56
pubmed: 17375121
Am J Epidemiol. 2006 May 15;163(10):929-37
pubmed: 16597706
Eur J Clin Nutr. 2015 Apr;69(4):449-54
pubmed: 25387899
Diabetologia. 2011 Sep;54(9):2272-82
pubmed: 21717116
Public Health Nutr. 2004 Sep;7(6):713-22
pubmed: 15369608
Diabetes Res Clin Pract. 2018 Apr;138:271-281
pubmed: 29496507
Am J Epidemiol. 2006 Sep 15;164(6):576-85
pubmed: 16801375
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
J Nutr. 2017 Jun;147(6):1174-1182
pubmed: 28424256
Am J Epidemiol. 2012 Jan 1;175(1):66-73
pubmed: 22135359
J Natl Cancer Inst. 2011 Jul 20;103(14):1086-92
pubmed: 21653922
Eur J Clin Nutr. 2005 Dec;59(12):1397-408
pubmed: 16160701
Am J Clin Nutr. 2012 Jan;95(1):184-93
pubmed: 22170373
Am J Clin Nutr. 2003 Feb;77(2):458-66
pubmed: 12540408
Crit Rev Food Sci Nutr. 2011 Oct-Nov;51(9):795-815
pubmed: 21888531
Hum Genet. 2009 Jun;125(5-6):507-25
pubmed: 19357868
Arch Intern Med. 2008 Jul 28;168(14):1493-9
pubmed: 18663161
BMJ. 2010 Aug 18;341:c4229
pubmed: 20724400
Nat Genet. 2017 Jan;49(1):17-26
pubmed: 27841877
Am J Clin Nutr. 2018 Nov 1;108(5):1069-1091
pubmed: 30475962
Stat Med. 2010 May 30;29(12):1282-97
pubmed: 19408255
Nature. 2015 Feb 12;518(7538):197-206
pubmed: 25673413

Auteurs

Ju-Sheng Zheng (JS)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
Key Laboratory of Growth Regulation and Translation Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China.

Stephen J Sharp (SJ)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.

Fumiaki Imamura (F)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.

Rajiv Chowdhury (R)

MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Thomas E Gundersen (TE)

Vitas AS, Oslo, Norway.

Marinka Steur (M)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.

Ivonne Sluijs (I)

Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.

Yvonne T van der Schouw (YT)

Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.

Antonio Agudo (A)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Group of Research on Nutrition and Cancer, Bellvitge Biomedical Research Institute, L'Hospitalet of Llobregat, Barcelona, Spain.

Dagfinn Aune (D)

School of Public Health, Imperial College London, London, UK.
Department of Nutrition, Bjørknes University College, Oslo, Norway.
Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.

Aurelio Barricarte (A)

Navarra Public Health Institute, Pamplona, Spain.

Heiner Boeing (H)

Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.

María-Dolores Chirlaque (MD)

Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain.
CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Miren Dorronsoro (M)

Public Health Division of Gipuzkoa, San Sebastian, Spain.

Heinz Freisling (H)

International Agency for Research on Cancer, Lyon, France.

Douae El-Fatouhi (D)

Centre of Research in Epidemiology and Population Health, UMR 1018 Inserm, Institut Gustave Roussy, Paris-Sud Paris-Saclay University, Villejuif, France.

Paul W Franks (PW)

Department of Clinical Sciences, Lund University, Malmö, Sweden.

Guy Fagherazzi (G)

Centre of Research in Epidemiology and Population Health, UMR 1018 Inserm, Institut Gustave Roussy, Paris-Sud Paris-Saclay University, Villejuif, France.
Luxembourg Institute of Health (LIH), Department of Population Health, Strassen, Luxembourg.

Sara Grioni (S)

Epidemiology and Prevention Unit, Milan, Italy.

Marc J Gunter (MJ)

International Agency for Research on Cancer, Lyon, France.

Cecilie Kyrø (C)

Danish Cancer Society Research Centre, Copenhagen, Denmark.

Verena Katzke (V)

Division of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany.

Tilman Kühn (T)

Division of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany.

Kay-Tee Khaw (KT)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Nasser Laouali (N)

Centre of Research in Epidemiology and Population Health, UMR 1018 Inserm, Institut Gustave Roussy, Paris-Sud Paris-Saclay University, Villejuif, France.

Giovanna Masala (G)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, Florence, Italy.

Peter M Nilsson (PM)

Department of Clinical Sciences, Lund University, Malmö, Sweden.

Kim Overvad (K)

Department of Public Health, Aarhus University, Aarhus, Denmark.
Department of Cardiology, Aalborg University Hospital, Aarhus, Denmark.

Salvatore Panico (S)

Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.

Keren Papier (K)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

J Ramón Quirós (JR)

Public Health Directorate, Asturias, Spain.

Olov Rolandsson (O)

Department of Public Health and Clinical Medicine, Family Medicine, Umeå University, Umeå, Sweden.

Daniel Redondo-Sánchez (D)

CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Andalusian School of Public Health, Granada, Spain.
Institute of Biosanitary Research of Granada, Granada, Spain.

Fulvio Ricceri (F)

Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Unit of Epidemiology, Regional Health Service ASL TO3, Grugliasco, Turin, Italy.

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
German Centre for Diabetes Research, Neuherberg, Germany.
University of Potsdam, Institute of Nutritional Sciences, Potsdam, Germany.

Annemieke M W Spijkerman (AMW)

National Institute for Public Health and the Environment, Bilthoven, Netherlands.

Anne Tjønneland (A)

Danish Cancer Society Research Centre, Copenhagen, Denmark.

Tammy Y N Tong (TYN)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Rosario Tumino (R)

Cancer Registry and Histopathology Department, Azienda Sanitaria Provinciale, Ragusa, Italy.

Elisabete Weiderpass (E)

International Agency for Research on Cancer, Lyon, France.

John Danesh (J)

MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
NIHR Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
British Heart Foundation Cambridge Centre of Excellence, Division of Cardiovascular Medicine, Addenbrooke's Hospital, Cambridge, UK.
Department of Human Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.

Adam S Butterworth (AS)

MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
NIHR Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Elio Riboli (E)

School of Public Health, Imperial College London, London, UK.

Nita G Forouhi (NG)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK nita.forouhi@mrc-epid.cam.ac.uk.

Nicholas J Wareham (NJ)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH